We use our own and third-party cookies to give you an improved browsing experience and to compile anonymous browsing statistics.

By continuing to browse our site, it is understood that you accept our use of cookies. You can change your settings at any time or open our Cookies Policy to learn more.

SENER Diagnostics

Press Releases



SENER appoints Xavier de Prado Business Development Manager of the Diagnostic Department


Xavier de Prado is the new Business Development and Marketing Manager of the Diagnostic Department, SENER Diagnostics. Since 2010, the SENER Group has had a company division in the field of healthcare technology that develops and markets solutions intended to offer automation systems that improve work flows in laboratories and hospitals, as well as to increase the quality of the tests and generate savings for the healthcare system.

Beckman Coulter Diagnostics in Partnership with NTE-SENER Announces European Launch of DxM 6100 Autoplak Advanced System

20/02/2018 Beckman Coulter Diagnostics and NTE-SENER are partnering to improve patient care throughout Europe by enhancing microbiology laboratory efficiency and effectiveness with the DxM 6100 Autoplak Advanced automated plate streaking system.

SENER Diagnostics has agreed with Hettich Labinstrument AB the AUTOPLAK distribution in Sweden

11/07/2016 SENER Group’s healthcare technology brand has signed a distribution agreement with the Swedish company Hettich Labinstrument AB.

SENER Diagnostics has agreed with Assista Elektronika GesmbH the AUTOPLAK distribution in Slovakia

30/06/2016 SENER Group’s healthcare technology brand has signed a distribution contract with the Austrian firm Assista Elektronika GesmbH.

SENER Diagnostics and DELTALAB are changing their collaboration agreement


SENER Diagnostics, part of the SENER engineering and technology group, and DELTALAB, two renowned companies in the field of healthcare technology, have decided to reshape the agreement they held up until now, whereby the AUTOPLAK inoculation and streaking device for liquid samples in Petri dishes, designed and manufactured by SENER Diagnostics, was marketed jointly.

SENER Group grows again in 2014

Turnover increased by 8% to reach 1.315 billion Euros, with net profit rising by 661 % to reach 57.8 million Euros.

of 26 results
1 - 2 - 3 - Next »
SENER Diagnostics C/Creu Casas i Sicart, 86-88 - Parc de l’Alba
08290 Cerdanyola del Vallès (Spain)
Tel. +34 932 283 300 - Fax. +34 932 283 316

Cookies policy

What are cookies?

A "cookie" is a small file with browsing information that is downloaded to the user's computer, tablet or smartphone.

The combined total of cookies from all of our users helps us to improve the quality of our website, letting us identify which pages are useful and which might need to be improved.

There is no way in which cookies can cause damage to your device. On the contrary, their use helps us to identify and solve errors.

What type of cookies does this website use?

Below are details of the types of cookies that are used in the sener.es website and their specific purposes:

Different sources:

Different lifespans:

Different purposes:

How do I delete cookies?

You can allow, block or delete cookies installed on your device by changing the settings of the browser installed on your device:

User's responsibilities:

By using this Website, the User expressly agrees to the use of information that is collected; the User also acknowledges awareness of the possibility to refuse the processing of such data or information by blocking Cookies in their browser settings. However, the option of blocking Cookies from the browser may inhibit full use of all of the Website's functions.

After reading all of the information provided, we inform the User that by continuing to browse our website without taking the appropriate measures to change the browser settings to block the installation of Cookies used by the website, under the terms included in article 22.2 of Law 34/2002 on Information Society Services and E-Commerce, in accordance with its drafting by RD 13/2012, of 30 March, the User contents to the use of the mechanisms referred to herein.